• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program.

作者信息

Wysocki Kenneth, Park Seo Young, Bleecker Eugene, Busse William, Castro Mario, Chung Kian Fan, Gaston Benjamin, Erzurum Serpil, Israel Elliot, Teague W Gerald, Moore Charity G, Wenzel Sally

机构信息

University of Pittsburgh, Pittsburgh, Pa.

Wake Forest University, Winston-Salem, NC.

出版信息

J Allergy Clin Immunol. 2014 Mar;133(3):915-8. doi: 10.1016/j.jaci.2013.10.031. Epub 2013 Dec 9.

DOI:10.1016/j.jaci.2013.10.031
PMID:24332222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4086875/
Abstract
摘要

相似文献

1
Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program.重度哮喘患者全身使用糖皮质激素相关因素的特征分析：来自重度哮喘研究项目的数据
J Allergy Clin Immunol. 2014 Mar;133(3):915-8. doi: 10.1016/j.jaci.2013.10.031. Epub 2013 Dec 9.
2
Mechanisms of corticosteroid resistance in asthma: role of airway remodelling.哮喘中皮质类固醇抵抗的机制：气道重塑的作用。
Can Respir J. 1998 Jan-Feb;5(1):63-5.
3
[Conditioning factors for corticotherapy of non-seasonal asthma. Usefulness of bronchial hyperreactivity].[非季节性哮喘皮质激素治疗的调节因素。支气管高反应性的效用]
Med Clin (Barc). 1986 Mar 22;86(11):450-3.
4
Progressive airflow limitation is a feature of children with severe asthma.进行性气流受限是严重哮喘儿童的特征。
J Allergy Clin Immunol. 2011 Jan;127(1):282-4. doi: 10.1016/j.jaci.2010.10.036.
5
Treatment of asthma in a general practice.基层医疗中哮喘的治疗
Postgrad Med J. 1984 May;60(703):336-7. doi: 10.1136/pgmj.60.703.336.
6
Normal lung function in children with mild to moderate persistent asthma well controlled by inhaled corticosteroids.吸入皮质类固醇可良好控制的轻度至中度持续性哮喘患儿的肺功能正常。
J Allergy Clin Immunol. 2006 Jul;118(1):280-2. doi: 10.1016/j.jaci.2006.03.013. Epub 2006 May 30.
7
End points in asthma.哮喘的终点指标
Can Respir J. 2003 Jan-Feb;10(1):9. doi: 10.1155/2003/142916.
8
GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma.GLCCI1基因的rs37973位点不影响白人哮喘患者对吸入性糖皮质激素的治疗反应。
J Allergy Clin Immunol. 2014 Feb;133(2):587-9. doi: 10.1016/j.jaci.2013.08.024. Epub 2013 Oct 13.
9
Triamcinolone acetonide aerosols for asthma. I. Effective replacement of systemic corticosteroid therapy.用于哮喘的曲安奈德气雾剂。I. 有效替代全身皮质类固醇疗法。
J Allergy Clin Immunol. 1976 Jan;57(1):1-11. doi: 10.1016/0091-6749(76)90073-7.
10
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.一项使用复合生物标志物算法调整皮质类固醇剂量与标准治疗相比，对重度哮喘患者进行皮质类固醇优化的随机实用试验：一项随机试验的研究方案。
Trials. 2018 Jan 4;19(1):5. doi: 10.1186/s13063-017-2384-7.

引用本文的文献

1
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.基于生物标志物的过敏性疾病和哮喘药物研发：美国食品药品监督管理局公开研讨会
J Allergy Clin Immunol. 2025 Jun;155(6):1753-1766. doi: 10.1016/j.jaci.2025.03.014. Epub 2025 Mar 26.
2
Aerobic physical training reduces severe asthma phenotype involving kinins pathway.有氧运动训练可减少涉及激肽途径的严重哮喘表型。
Mol Biol Rep. 2024 Apr 10;51(1):499. doi: 10.1007/s11033-024-09474-w.
3
Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.在严重哮喘中口服皮质类固醇的使用趋势：一项为期 14 年的基于人群的研究。
Respir Res. 2021 Apr 9;22(1):103. doi: 10.1186/s12931-021-01696-x.
4
Immune responses and exacerbations in severe asthma.严重哮喘的免疫反应和恶化。
Curr Opin Immunol. 2021 Oct;72:34-42. doi: 10.1016/j.coi.2021.03.004. Epub 2021 Mar 24.
5
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.严重成人哮喘：整合临床特征、生物学和治疗方法以改善结局。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):809-821. doi: 10.1164/rccm.202009-3631CI.
6
Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study.支气管扩张症与依赖皮质类固醇的重症哮喘患者死亡率增加：一项全国性人群研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963030. doi: 10.1177/1753466620963030.
7
Coexisting COPD Increases Mortality in Patients With Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study.并存慢性阻塞性肺疾病增加依赖皮质类固醇哮喘患者的死亡率：一项基于全国人口的研究
Allergy Asthma Immunol Res. 2020 Sep;12(5):821-831. doi: 10.4168/aair.2020.12.5.821.
8
Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?我们是否满足了哮喘的表型和精准医学的承诺？
Physiol Rev. 2020 Jul 1;100(3):983-1017. doi: 10.1152/physrev.00023.2019. Epub 2020 Jan 9.
9
Neutrophilic Inflammation in Asthma and Association with Disease Severity.中性粒细胞性炎症在哮喘中的作用及其与疾病严重程度的关系。
Trends Immunol. 2017 Dec;38(12):942-954. doi: 10.1016/j.it.2017.07.003. Epub 2017 Aug 4.
10
Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?严重哮喘表型——它们应如何指导评估和治疗？
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):901-908. doi: 10.1016/j.jaip.2017.05.015.

本文引用的文献

1
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation.哮喘中的一氧化氮和相关酶：与严重程度、酶功能和炎症的关系。
Clin Exp Allergy. 2012 May;42(5):760-8. doi: 10.1111/j.1365-2222.2011.03860.x. Epub 2011 Sep 25.
2
Inflammatory biomarkers in severe asthma.严重哮喘中的炎症生物标志物。
Curr Opin Pulm Med. 2012 Jan;18(1):35-41. doi: 10.1097/MCP.0b013e32834d09a5.
3
Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma.肥胖对哮喘急性发作严重程度及治疗反应性的影响。
J Asthma. 2011 Aug;48(6):546-52. doi: 10.3109/02770903.2011.581733. Epub 2011 May 23.
4
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.使用呼出气一氧化氮测量来识别哮喘患者中具有反应性和风险的表型。
Am J Respir Crit Care Med. 2010 May 15;181(10):1033-41. doi: 10.1164/rccm.200905-0695OC. Epub 2010 Feb 4.
5
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.美国国立心肺血液研究所严重哮喘研究项目对严重哮喘表型的特征描述。
J Allergy Clin Immunol. 2007 Feb;119(2):405-13. doi: 10.1016/j.jaci.2006.11.639.
6
The Biomolecular Interaction Network Database and related tools 2005 update.生物分子相互作用网络数据库及相关工具2005年更新版
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D418-24. doi: 10.1093/nar/gki051.
7
"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.重度哮喘中“难治性”嗜酸性气道炎症：胃肠外糖皮质激素的作用
Am J Respir Crit Care Med. 2004 Sep 15;170(6):601-5. doi: 10.1164/rccm.200404-440OC. Epub 2004 Jun 23.
8
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients.哮喘患者吸入丙酸倍氯米松治疗后呼出一氧化氮下降的剂量反应关系及可重复性。
Chest. 2001 May;119(5):1322-8. doi: 10.1378/chest.119.5.1322.
9
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.有证据表明，重度哮喘在病理上可分为两种具有不同生理和临床特征的炎症亚型。
Am J Respir Crit Care Med. 1999 Sep;160(3):1001-8. doi: 10.1164/ajrccm.160.3.9812110.